Featured Research

from universities, journals, and other organizations

Certain risk factors for ACL re-injury identified

Date:
July 11, 2014
Source:
American Orthopaedic Society for Sports Medicine (AOSSM)
Summary:
Re-tearing a repaired knee Anterior Cruciate Ligament (ACL) happens all too frequently, however a recent study suggests that identification and patient education regarding modifiable risk factors may minimize the chance of a future ACL tear.

Re-tearing a repaired knee Anterior Cruciate Ligament (ACL) happens all too frequently, however a recent study being presented today at the American Orthopaedic Society for Sports Medicine's (AOSSM) Annual Meeting suggests that identification and patient education regarding modifiable risk factors may minimize the chance of a future ACL tear.

"Our research suggests that a few risk factors such as, age, activity level and type of graft utilized may point to the possibility of re-injury," said lead author, Christopher C. Kaeding, MD of the Ohio State University. "However, with better education about adjustments that can be made, based on these risk factors, patients may be able to minimize re-tears."

Kaeding and his team analyzed data from 2,695 patients through the MOON ACL injury database from 2002-2008. All patients had a primary ACL reconstruction with no history of contralateral knee surgery. Graft type, age, Mark score, sport played after surgery, sex, smoking status, meniscal tear status and Body Mass Index (BMI) were identified as criteria for inclusion into the study.

In the results, 116/2695 (4.3%) had a graft re-tear on the same side of the body and 97/2695 (3.6%) had a re-tear on the opposite side. The odds of re-tearing the same ACL, decreased by nine percent for each year of increased age. The odds of re-tear on the opposite ACL, decreased by four percent for every year of increased age.

"The study highlights that younger age, higher activity levels at time of injury and what type of graft used (allograft) may increase risk of same side ACL injury within two years. With individuals having higher activity levels and lower age re-tears on the opposite leg were more prominent," said Kaeding. "Physicians and physical therapists need to better educate our patients about continued neuro-muscular training even after the immediate rehabilitation process has ended to help prevent future tears."


Story Source:

The above story is based on materials provided by American Orthopaedic Society for Sports Medicine (AOSSM). Note: Materials may be edited for content and length.


Cite This Page:

American Orthopaedic Society for Sports Medicine (AOSSM). "Certain risk factors for ACL re-injury identified." ScienceDaily. ScienceDaily, 11 July 2014. <www.sciencedaily.com/releases/2014/07/140711091820.htm>.
American Orthopaedic Society for Sports Medicine (AOSSM). (2014, July 11). Certain risk factors for ACL re-injury identified. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/07/140711091820.htm
American Orthopaedic Society for Sports Medicine (AOSSM). "Certain risk factors for ACL re-injury identified." ScienceDaily. www.sciencedaily.com/releases/2014/07/140711091820.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins